These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4906150)

  • 1. A preliminary report on the clinical evaluation of a new antihypertensive--GO. 1507--CIBA.
    Billimoria AR; Shah SJ; Mehta AJ; Anand MP; Kumar H
    Indian Heart J; 1968 Oct; 20(4):406-22. PubMed ID: 4906150
    [No Abstract]   [Full Text] [Related]  

  • 2. A preliminary report on the clinical evaluation of a new antihypertensive agent-Go 4416 CIBA.
    Shah SJ; Billimoria AR; Haveliwala HK; Vibhakar BB; Kumar H
    Indian Heart J; 1971 Apr; 23(2):164-7. PubMed ID: 5154112
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials with CIBA 1507--Go, a new antihypertensive compound.
    Misra RC; Gupta SK; Chuttani HK
    J Assoc Physicians India; 1970 Dec; 18(12):979-82. PubMed ID: 5509035
    [No Abstract]   [Full Text] [Related]  

  • 4. Prazosin in the treatment of hypertension - a preliminary report.
    Rab SM; Farooqui S
    Br J Clin Pract; 1975 Dec; 29(12):337-8 passim. PubMed ID: 764840
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hypertension with urapidil].
    Fetkovská N; Dzúrik R
    Cas Lek Cesk; 1985 Oct; 124(41-42):1292-5. PubMed ID: 3902242
    [No Abstract]   [Full Text] [Related]  

  • 6. [Urapidil in primary arterial hypertension].
    Román O; Sudy E; Gac JC; Valenzuela MA
    Rev Med Chil; 1987 Jul; 115(7):648-54. PubMed ID: 3331026
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hypertensive crisis with ebrantil (urapidil)].
    Mleczko-Nycz Z; Kokot F
    Wiad Lek; 1984 Jun; 37(11):817-20. PubMed ID: 6390979
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hypertension with alpha blockade or ACE inhibition. Multicenter double-blind study of urapidil versus captopril].
    Rosenthal J; Haerlin R
    Fortschr Med; 1986 Oct; 104(40):763-6. PubMed ID: 3536700
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trials of urapidil. Review of human pharmacological studies with a summary of a multi-center study].
    Bruckschen EG; Henze F; Michael G
    Arzneimittelforschung; 1978; 28(7):1176-84. PubMed ID: 385007
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolically neutral therapy of hypertension. An open, multicenter, prospective long-term study of the tolerance, safety and effectiveness of urapidil].
    Liebau H; Wurst W; Harder I; Solleder P
    Fortschr Med; 1988 Nov; 106(32):651-4. PubMed ID: 3148534
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative clinical study of the antihypertensive effects of urapidil versus diazoxide in patients with severe arterial hypertension].
    Gasparović V; Vrhovac B; Rumboldt Z; Ivanković D
    Lijec Vjesn; 1986; 108(11-12):494-6. PubMed ID: 3553816
    [No Abstract]   [Full Text] [Related]  

  • 12. Prazosin hydrochloride (CP-12,299-1), an oral anti-hypertensive agent: preliminary clinical observations in ambulatory patients.
    Cohen BM
    J Clin Pharmacol J New Drugs; 1970; 10(6):408-17. PubMed ID: 4920492
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of the antihypertensive effects of debrisoquin, a new postganglionic vasodepressor agent.
    Talbot FJ
    Med Ann Dist Columbia; 1965 Dec; 34(12):580-3. PubMed ID: 5321849
    [No Abstract]   [Full Text] [Related]  

  • 14. Debrisoquin sulfate: a clinical evaluation of a new antihypertensive agent.
    Blechman M; Sokol C; Moser M
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):71-6. PubMed ID: 4975816
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary experience with a new postganglion-blocking agent for the management of hypertension.
    Belle MS; Gilmore HR; Keyes MH; Sanford H
    J Fla Med Assoc; 1968 Dec; 55(12):1081-4. PubMed ID: 4881916
    [No Abstract]   [Full Text] [Related]  

  • 16. [Urapidil as a basic drug in severe hypertension].
    Thuma G
    Fortschr Med; 1986 Jun; 104(22):457-460. PubMed ID: 3744250
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies with the new antihypertensive agent Catapresan].
    Jüngling K
    Med Welt; 1968 Sep; 39():2105-13. PubMed ID: 4887319
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and hemodynamic study of a new antihypertensive agent].
    Palmero HA; Caeiro AE; Lussi H; Massari P; Amuchastegui S
    Prensa Med Argent; 1968 Aug; 55(25):1212-6. PubMed ID: 4885121
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of Envacar in the treatment of hypertension].
    Kocemba J; Mareczek S
    Przegl Lek; 1968; 24(2):330-2. PubMed ID: 4867414
    [No Abstract]   [Full Text] [Related]  

  • 20. Prazoxin - a new antihypertensive agent.
    Rougier M; Lahon HF; Cini AR
    Br J Clin Pract; 1974 Aug; 28(8):280-4. PubMed ID: 4458796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.